KR

KORU Medical Systems IncNASDAQ KRMD Stock Report

Last reporting period 31 Dec, 2023

Updated 21 Nov, 2024

Last price

Market cap $B

0.123

Micro

Exchange

XNAS - Nasdaq

KRMD Stock Analysis

KR

Uncovered

KORU Medical Systems Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-34/100

Low score

Market cap $B

0.123

Dividend yield

Shares outstanding

45.519 B

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 85 full-time employees. The firm is focused on home and specialty infusion solutions. The Company’s products include FREEDOM Syringe Infusion System, which includes the FREEDOM60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. The devices are used for infusions administered in the home and alternate care settings. The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate what the system delivers. The firm delivers immunoglobulin therapies to patients with chronic illnesses, such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). The firm serves patients, patient advocates, specialty pharmacies, distributors, clinicians, doctors and nurses and investors.

View Section: Eyestock Rating